India’s role in increasing access to HCV drugs

Early intervention by the Indian government and civil society will be essential to overcome patent barriers to ensure that the new drugs …

Introduction of ‘data exclusivity’ in pesticides Bill will affect farmers

Certain clauses in the Bill threaten to delay the entry of affordable generic products in the market

Activists demand compulsory licence for another life-saving cancer drug

Appellate board's order upholding Natco's CL for sorafenib tosylate may pave way for manufacture of generic version of other patented drugs

Getting the drug equation right

Sonal Matharu reports how fights over counterfeit drugs and low-quality drugs is suppressing the larger issue of drug safety

Will appellate body uphold grant of compulsory licence to cancer drug?

Hearing on Bayer's appeal against manufacture of generic version of Nexavar to conclude this week

Novartis loses patent appeal in landmark suit

Supreme Court upholds amended law that bars patents for insignificant improvements to an existing drug—in this case anti-cancer drug …

Time to wake up to threat of NCDs

As the UN begins its meeting to devise strategies to tackle NCDs, Indian public health activists say it was a wake-up call for the health …

Non-communicable diseases: The unrecognised public health threat

Health is rarely the topic of discussion at the UN general assembly. But starting September 19, the UN began a high-level meeting to debate a …

Vaccinate 40% people everywhere before rolling out booster doses: Soumya Swaminathan

Decision on Covaxin in 4-6 weeks, says WHO chief scientist at DTE webinar

US approves new drug that can cure even drug resistant TB

Experts, activists seek new regime for its rational use

Call to make healthy choices available and affordable

Health experts lash out at food industry for putting public health at risk

DTE Reportage

'Lifestyle' diseases spur UN to act